Breast reconstruction with pedicled TRAM flap The pedicle transverse rectus abdominus myocutaneous flap (TRAM) is widely used for breast reconstruction, however is not exempt from complications. Between 2004 and 2010 the authors performed breast reconstruction after total mastectomy in 52 patients with pedicled TRAM flaps. Purpose: To describe the demography, outcomes and complications in patients operated for breast cancer and reconstructed with TRAM flap. To assess the influence of smoking, the laterality and timing of reconstruction. Material and Method: Retrospective, observational and comparative. We reviewed the medical records of 52 patients operated by the authors between 2004 and 2010. Four cases were excluded due to incomplete data. Results: In the 48 patients studied were 50 TRAM flaps. The most frequent comorbidity was smoking (27%). Regarding the timing of reconstruction, 74% (37) was performed immediately post-mastectomy and 26% (13) was deferred. Was used by 78% (39) ipsilateral TRAM, 18% (9) contralateral and 4% (2) bilateral. Only minor complications were observed and the cosmetic result evaluated by the surgeon's satisfaction was very good or excellent in 62% (31). Smoking, timing of reconstruction and laterality did not affect in complications or cosmetic outcome (p > 0.05). Conclusions: The pedicled TRAM flap is an excellent alternative for reconstruction in breast cancer patients. It is not exempt from complications, with a tendency to get better cosmetic results in the non-smoker group.
Phyllodes tumor of the breastIntroduction: The phyllodes tumor (PT) of the breast is a rare disease of unknown origin. Despite its classification into benign, borderline and malignant, their behavior tends to be uncertain. Because of this, treatment remains controversial. Objective: To describe the management of the FT in breast pathology unit of our hospital and their outcomes. Material and Methods: We retrospectively reviewed the files of the patients with PT, operated in our hospital between 2001 and 2008. We analyzed the clinical characteristics, diagnostic studies, treatment and outcomes. Results: During this period 12 patients were operated. The average age was 42 ± 15.2 years (16-64) and usually the form of presentation was painless palpable nodule. Both mammography and ultrasound were unable to suggest the diagnosis. Eight patients had core biopsy, which revealed the diagnosis of PT in 5, while in the other 3 was fibroadenoma. All patients underwent a partial mastectomy. The biopsy showed six benign, two borderline and two malignant PT. The latter two patients received adjuvant radiotherapy. At the end of this study, 2 patients had relapsed at 12 and 30 months (borderline and benign, respectively). There were no cases of lymphatic or distant metastases. Conclusions: The PT has a low frequency of presentation and preoperative diagnosis is difficult, so we recommend a core biopsy, but it can confuse with fibroadenoma. The management with partial mastectomy and negative borders had a recurrence rate of 18% in this series. ResumenIntroducción: El tumor filoides (TF) de la mama es una patología poco frecuente y origen desconocido. A pesar de su clasificación en benignos, borderline y malignos, su comportamiento tiende a ser incierto. Debido a esto su tratamiento sigue siendo controversial. Objetivo: Describir el manejo del TF en la unidad de Rev.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.